Exact Sciences Corp EXAS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:11 PM EDT
63.62quote price arrow up+1.21 (+1.94%)
Volume
358,002
52 week range
56.05 - 100.77
Loading...
  • Open62.60
  • Day High64.73
  • Day Low62.42
  • Prev Close62.41
  • 52 Week High100.77
  • 52 Week High Date07/19/23
  • 52 Week Low56.05
  • 52 Week Low Date02/28/24

Key Stats

  • Market Cap11.549B
  • Shares Out181.53M
  • 10 Day Average Volume2.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change-13.95

KEY STATS

  • Open62.60
  • Day High64.73
  • Day Low62.42
  • Prev Close62.41
  • 52 Week High100.77
  • 52 Week High Date07/19/23
  • 52 Week Low56.05
  • 52 Week Low Date02/28/24
  • Market Cap11.549B
  • Shares Out181.53M
  • 10 Day Average Volume2.70M
  • Dividend-
  • Dividend Yield-
  • Beta1.25
  • YTD % Change-13.95

RATIOS/PROFITABILITY

  • EPS (TTM)-1.14
  • P/E (TTM)-56.04
  • Fwd P/E (NTM)-75.11
  • EBITDA (TTM)-7.783M
  • ROE (TTM)-6.60%
  • Revenue (TTM)2.50B
  • Gross Margin (TTM)73.83%
  • Net Margin (TTM)-8.17%
  • Debt To Equity (MRQ)75.79%

EVENTS

  • Earnings Date05/08/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Exact Sciences Corp

 

Profile

MORE
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test Development. The Company’s products and services include Cologuard test, Oncotype DX...
Kevin Conroy
Chairman of the Board, President, Chief Executive Officer
Jeffrey Elliott
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Aaron Bloomer
Chief Financial Officer
Sarah Condella
Executive Vice President - Human Resources
Address
5505 Endeavor Lane
Madison, WI
53719
United States

Top Peers

SYMBOLLASTCHG%CHG
MEDP
Medpace Holdings Inc
398.56+22.30+5.93%
NBIX
Neurocrine Biosciences Inc
140.15+6.49+4.86%
SRPT
Sarepta Therapeutics Inc
118.77+1.81+1.55%
INCY
Incyte Corp
51.82-0.10-0.19%
NTRA
Natera Inc
91.51+2.90+3.27%